Serious infections caused by methicillin-resistant Staphylococcus aureus.

Abstract

Although first identified just >4 decades ago, methicillin-resistant Staphylococcus aureus (MRSA) has undergone rapid evolutionary changes and epidemiologic expansion to become a major cause of nosocomial and community-acquired infections worldwide. Increasing resistance to vancomycin among MRSA strains in conjunction with availability of new antibiotics, including daptomycin and linezolid, have increased treatment choices but made clinical treatment decisions more challenging. This article describes the clinical features and management issues of 2 challenging-to-treat manifestations of MRSA infection, bacteremia and/or endocarditis and osteomyelitis. It also presents a brief review of community-associated MRSA infections and preventive strategies directed against MRSA.

DOI: 10.1086/653519
01002003002011201220132014201520162017
Citations per Year

1,258 Citations

Semantic Scholar estimates that this publication has 1,258 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Boucher2010SeriousIC, title={Serious infections caused by methicillin-resistant Staphylococcus aureus.}, author={Helen W. Boucher and Loren G Miller and Raymund Rabe Razonable}, journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, year={2010}, volume={51 Suppl 2}, pages={S183-97} }